The funding round was co-led by Catalytic Capital for Climate and Health (C3H), a catalytic investment vehicle by Temasek Trust, and Singapore-based Kibo Invest, which is focused on supporting climate technology.
Alongside additional participation from a consortium of global investors, the capital is expected to support the engineering of Equatic’s first 100-kilotonne carbon dioxide removal (CDR) commercial facility in Canada.
H2 View understands that the facility will capture 100,000 tonnes of atmospheric CO2 per year, while simultaneously producing green hydrogen through seawater electrolysis.
The Canada site will be Equatic’s first commercial-scale plant, complemented by the scale-up of its Singapore demonstration facility.
Gaurav Sant, Founder and Chief Technology Officer at Equatic, said the investment enables the firm to scale production capabilities and accelerate its “mission to deliver durable carbon removal at scale.”
Last year, Equatic announced it would begin developing oxygen-selective anodes (OSAs) at its San Diego facility, which enable hydrogen production from ocean water, cut costs and extend the lifespan to help Equatic target sub-$100-per-tonne carbon removal by 2030.
They are already planned for use in both the Singapore demonstration plant and the commercial-scale facility in Canada.
Newsletters
H2 View knows just how much hydrogen news there is to keep on top of. Keep up to date on the latest developments across the industry with our daily newsletter that will give you the top five stories of the day, straight to your inbox.
Don’t forget we also have our weekly newsletter which includes a round-up of the past seven days’ hydrogen highlights, including not only news but also interviews, features and analysis.
Sign up for our newsletters here.